AmerisourceBergen aims to make digital therapeutics access easier
pharmaphorum
JULY 27, 2022
AmerisourceBergen notes that the US market for DTx is predicted to grow at a compound annual growth rate of nearly 25% between 2022 to 2030, according to figures from Grand View Research which valued the category at $4.2 billion in 2021.
Let's personalize your content